Immuron chairman transition

Melbourne, australia, june 30, 2023 (globe newswire) -- immuron limited (asx: imc; nasdaq: imrn), an australian based and globally integrated biopharmaceutical company, is pleased to announce the transition of paul brennan from non-executive director to chairman, effective july 1, 2023. dr roger aston will continue on the board, transitioning from chairman to non-executive director.
IMRN Ratings Summary
IMRN Quant Ranking